PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
1.30M / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-82.06%
Negative revenue growth while ANO.AX stands at 62.13%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-66.00%
Negative gross profit growth while ANO.AX is at 251.94%. Joel Greenblatt would examine cost competitiveness or demand decline.
-123.40%
Negative EBIT growth while ANO.AX is at 155.25%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-123.40%
Negative operating income growth while ANO.AX is at 648.74%. Joel Greenblatt would press for urgent turnaround measures.
-139.08%
Negative net income growth while ANO.AX stands at 161.71%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-140.00%
Negative EPS growth while ANO.AX is at 161.29%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-142.11%
Negative diluted EPS growth while ANO.AX is at 161.54%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.85%
Share count expansion well above ANO.AX's 0.62%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-0.12%
Reduced diluted shares while ANO.AX is at 0.46%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
129.64%
Positive OCF growth while ANO.AX is negative. John Neff would see this as a clear operational advantage vs. the competitor.
120.13%
Positive FCF growth while ANO.AX is negative. John Neff would see a strong competitive edge in net cash generation.
142.30%
10Y revenue/share CAGR at 50-75% of ANO.AX's 223.10%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
-24.58%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
13.36%
3Y revenue/share CAGR above 1.5x ANO.AX's 6.96%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
657.42%
10Y OCF/share CAGR above 1.5x ANO.AX's 77.99%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
333.39%
Positive OCF/share growth while ANO.AX is negative. John Neff might see a comparative advantage in operational cash viability.
565.52%
3Y OCF/share CAGR at 50-75% of ANO.AX's 878.66%. Martin Whitman would suspect weaker recent execution or product competitiveness.
-650.00%
Negative 10Y net income/share CAGR while ANO.AX is at 4293.06%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-287.50%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-475.00%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
4382.33%
10Y equity/share CAGR above 1.5x ANO.AX's 813.84%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
132.10%
5Y equity/share CAGR above 1.5x ANO.AX's 53.02%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
73.11%
3Y equity/share CAGR above 1.5x ANO.AX's 0.05%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while ANO.AX invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-41.70%
Firm’s AR is declining while ANO.AX shows 53.52%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
4.93%
We show growth while ANO.AX is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-9.39%
Negative asset growth while ANO.AX invests at 3.20%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-11.60%
We have a declining book value while ANO.AX shows 2.14%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-63.18%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-1.16%
We cut SG&A while ANO.AX invests at 14.86%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.